Jagsonpal Pharmaceuticals Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|
| Revenue | 78.44 | 61.33 | 99.53 |
| Operating Expense | 61.40 | 50.06 | 58.19 |
| Net Profit | 10.80 | 6.58 | 31.99 |
| Net Profit Margin | 13.77 | 10.73 | 32.14 |
| Earning Per Share | 1.60 | 0.98 | 4.74 |
| EBIDTA | 16.57 | 10.39 | 42.72 |
| Effective Tax Rate | 18.60 | 11.00 | 19.50 |
| Particulars | Jun 2025 |
|---|---|
| Revenue | 78.44 |
| Operating Expense | 61.40 |
| Net Profit | 10.80 |
| Net Profit Margin | 13.77 |
| Earning Per Share | 1.60 |
| EBIDTA | 16.57 |
| Effective Tax Rate | 18.60 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 268.72 | 208.70 | 236.71 |
| Operating Expenses Annual | 217.65 | 185.64 | 202.56 |
| Operating Profit Annual | 78.95 | 32.35 | 36.43 |
| Interest Annual | 0.96 | 0.81 | 0.41 |
| Depreciation | 1.75 | 1.66 | 1.18 |
| Net Profit Annual | 55.36 | 22.46 | 26.72 |
| Tax Annual | 14.50 | 7.41 | 8.09 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 268.72 |
| Operating Expenses Annual | 217.65 |
| Operating Profit Annual | 78.95 |
| Interest Annual | 0.96 |
| Depreciation | 1.75 |
| Net Profit Annual | 55.36 |
| Tax Annual | 14.50 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 12.76 | 11.05 | 22.53 |
| Cash Flow from Operations | 55.30 | 35.17 | 46.66 |
| Cash Flow from Investing | -45.15 | -24.55 | -57.67 |
| Cash Flow from Financing | -11.70 | -8.91 | -0.46 |
| Cash Flow at the End | 11.22 | 12.76 | 11.05 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 12.76 |
| Cash Flow from Operations | 55.30 |
| Cash Flow from Investing | -45.15 |
| Cash Flow from Financing | -11.70 |
| Cash Flow at the End | 11.22 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 22.05 | 15.50 | 15.39 |
| PBIT Margin (%) | 19.03 | 14.70 | 14.87 |
| PBT Margin (%) | -0.79 | -3.45 | -21.42 |
| Net PROFIT Margin (%) | 20.60 | 10.76 | 11.29 |
| Return On Networth / Equity (%) | 18.58 | 12.97 | 18.32 |
| Return On Networth /Employed (%) | 22.82 | 16.89 | 23.48 |
| Return On Assets (%) | 24.72 | 12.38 | 17.84 |
| Total Debt / Equity (X) | 0.04 | 0.04 | 0.02 |
| Asset Turnover Ratio (%) | 1.20 | 1.15 | 1.58 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 22.05 |
| PBIT Margin (%) | 19.03 |
| PBT Margin (%) | -0.79 |
| Net PROFIT Margin (%) | 20.60 |
| Return On Networth / Equity (%) | 18.58 |
| Return On Networth /Employed (%) | 22.82 |
| Return On Assets (%) | 24.72 |
| Total Debt / Equity (X) | 0.04 |
| Asset Turnover Ratio (%) | 1.20 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 94.45 | 9.30 | 24.28 |
| Total Current Assets Annual | 161.19 | 196.78 | 164.56 |
| Non Current Assets Annual | 117.07 | 20.30 | 30.39 |
| Total Shareholders Funds Annual | 239.95 | 187.40 | 158.89 |
| Total Assets Annual | 278.26 | 217.08 | 194.95 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 94.45 |
| Total Current Assets Annual | 161.19 |
| Non Current Assets Annual | 117.07 |
| Total Shareholders Funds Annual | 239.95 |
| Total Assets Annual | 278.26 |
No Data Availabe
